1995

• Quest Laboratories established from the amalgamation of The Medical Laboratory, Health Medical and Quest Laboratories in Singapore.

1996

• Innovative Diagnostics established as a subsidiary of Singhealth.
• Gribbles Pathology begins operations in Malaysia.

2003

• Gribbles becomes the first major private pathology laboratory in Malaysia to be accredited by NATA.

2008

• Quest Laboratories accredited with ISO 15189 Singapore Laboratory Accreditation Scheme (SAC-SINGLAS) by the Singapore Accreditation Council (SAC).

2009

• Safework Laboratories accredited by NATA in Australia.

2010

• Clinipath is accredited by Standards Malaysia.

2011

• Innovative Diagnostics changes ownership to a group of doctors and lab operators led by Dr. Chris Ting.
• Quest's entry into Vietnam with a laboratory at Hanh Phuc Women & Children's Hospital in Ho Chi Minh City.

2012

• Dr. Chris Ting founds Quantum Diagnostics in Malaysia.

2015

• Innovative Diagnostics is the first multi-disciplinary private medical laboratory in Singapore to become a College of American Pathologists (CAP) accredited laboratory.

2016

• Quest Laboratories becomes the only private independent full-service laboratory in Singapore to hold dual international accreditation (CAP and SINGLAS).
• Innovative Diagnostics is recognized by the Westgard Sigma Verification Program - the first medical institution in Singapore to be so awarded.

2017

• BioMark is founded.
• GenomixLab recognised as the Best Advanced Genomics Laboratory at INPenang Awards 2017

2018

• At the ASEAN Rice Bowl Startup Awards, Biomark wins the award for the Best Health Tech Startup in ASEAN.
• Pathology Asia is founded with the acquisition of Gribbles Pathology, Quantum Diagnostics, Innovative Diagnostics and Quest Laboratories by TPG Capital.

2019

• Pathology Asia acquires Safework Laboratories in Australia; and Clinipath in Malaysia.
• Announcement of Merger of Innovative Diagnostics and Quest Laboratories in Singapore.

2020

• GenomixLab becomes the only CAP-accredited genetic diagnostics lab in Malaysia.
• Pathology Asia acquires Advanced Genomics, the parent company of GenomixLab; and BioMark.
• GenomixLab wins the award for Advanced Genetic Centre Provider of the Year in the Asia-Pacific at the Global Health Asia-Pacific Awards.

2021

• Innoquest Diagnostics Pte. Ltd. is officially launched from the merger of Innovative Diagnostics and Quest Laboratories in Singapore.
• LifeStrands is founded and launched in Singapore.
• Pathology Asia acquires Singapore Diagnostics in the Philippines and TissuPath in Australia.
• Expansion into digital therapeutics and wellness with a minority investment in Naluri.

2022

• Gribbles Pathology is officially rebranded to Innoquest Pathology Sdn. Bhd.
• Gribbles Pathology receives College of American Pathologists (CAP) accreditation, becoming the only dual-accredited laboratory in Malaysia.
• Innoquest Indonesia is established in Jakarta and receives the license to operate from the Ministry of Health, Indonesia (KKRI). Innoquest Indonesia currently operates from a Core Lab in Kuningan.
• LifeStrands Genomics receives CAP and ISO accreditations in Singapore.
• Lifestrands Genomics acquires DNA Lab in Malaysia, becoming the largest reproductive genetics player in Malaysia.
• SGD receives CAP accreditation in the Philippines.

2023

• Merger of GenomixLab and DNA Lab.
• LifeStrands Australia is established in Victoria, Australia.
• Lifestrands Australia receives both NATA and RCPA accreditations.
• Safework Labs Australia is rebranded to Safework Health.